In 2002, the FDA granted Medtronic Inc. approval for its Infuse Bone Graft, a man-made bone growth product for limited use in the lumbar spine region.

Alleged Promotion of Off-Label Use

Despite this limited scope of approval, Medtronic, Inc. allegedly promoted off-label uses of the Infuse® Bone Graft, including surgeries in the cervical spine, the thoracic spine, and also lateral and posterior approach of the lumbar spine.

Off-Label Use Linked to Injuries 

  • Severe swelling of the neck or throat
  • Excess bone growth in the spine
  • Chronic and severe pain in the legs or arms (inflammatory reaction)
  • Male infertility
  • Pancreatic, prostate, or breast cancer
  • Nerve damage
  • Death

Peterson & Associates, P.C. fights hard to make sure medical device companies take responsibility for the pain and suffering they cause. Get immediate legal assistance by calling us.

Post A Comment